ACTA1 and Hepatic fibrosis: Additionally, OCA leads to a reduction in sodium+/taurocholate cotransporting polypeptide, influencing BA circulation and subsequently lowering the expression of α-SMA in human HSCs, thereby attenuating liver fibrosis [47].